UnitedHealth Group Incorporated (NYSE:UNH) Stock Position Boosted by Forum Financial Management LP

Forum Financial Management LP increased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 25.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 8,480 shares of the healthcare conglomerate's stock after purchasing an additional 1,709 shares during the quarter. Forum Financial Management LP's holdings in UnitedHealth Group were worth $4,290,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently modified their holdings of UNH. NewSquare Capital LLC bought a new position in shares of UnitedHealth Group during the fourth quarter valued at $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new position in UnitedHealth Group in the fourth quarter valued at about $26,000. Hurley Capital LLC bought a new position in shares of UnitedHealth Group in the fourth quarter worth about $28,000. AlphaMark Advisors LLC bought a new position in shares of UnitedHealth Group in the fourth quarter worth about $30,000. Finally, Aster Capital Management DIFC Ltd purchased a new stake in shares of UnitedHealth Group during the fourth quarter worth about $30,000. 87.86% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on the company. Raymond James cut UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a report on Wednesday, May 14th. Wells Fargo & Company reduced their target price on UnitedHealth Group from $677.00 to $351.00 and set an "overweight" rating on the stock in a research report on Wednesday, May 14th. JPMorgan Chase & Co. lowered their target price on UnitedHealth Group from $525.00 to $405.00 and set an "overweight" rating on the stock in a research note on Thursday, May 15th. Wolfe Research reduced their target price on UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating for the company in a report on Tuesday, May 20th. Finally, Argus cut UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Monday, April 21st. One analyst has rated the stock with a sell rating, seven have given a hold rating, seventeen have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, UnitedHealth Group presently has an average rating of "Moderate Buy" and a consensus price target of $441.87.

UnitedHealth Group Stock Performance

NYSE:UNH traded down $0.58 during trading hours on Tuesday, reaching $294.99. 19,673,766 shares of the company's stock were exchanged, compared to its average volume of 10,605,672. The firm has a market capitalization of $267.60 billion, a price-to-earnings ratio of 19.03, a P/E/G ratio of 1.37 and a beta of 0.56. The company has a 50-day moving average of $448.25 and a 200 day moving average of $501.48. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 1-year low of $248.88 and a 1-year high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same quarter last year, the business posted $6.91 EPS. Research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

Insider Activity

In other UnitedHealth Group news, Director Kristen Gil acquired 3,700 shares of the firm's stock in a transaction on Thursday, May 15th. The stock was bought at an average cost of $271.17 per share, for a total transaction of $1,003,329.00. Following the completion of the purchase, the director now directly owns 3,818 shares in the company, valued at $1,035,327.06. This represents a 3,135.59% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Stephen J. Hemsley bought 86,700 shares of UnitedHealth Group stock in a transaction dated Friday, May 16th. The shares were purchased at an average cost of $288.57 per share, for a total transaction of $25,019,019.00. Following the completion of the transaction, the chief executive officer now owns 679,493 shares of the company's stock, valued at approximately $196,081,295.01. This represents a 14.63% increase in their position. The disclosure for this purchase can be found here. Insiders bought a total of 109,408 shares of company stock valued at $31,607,768 over the last 90 days. Insiders own 0.33% of the company's stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.